USE OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE IN PATIENTS WITH LIVER DISEASE

被引：0
|
作者：
Larson, Jared
Coler, Emily
Vakayil, Victor
Chandrashekar, Malavika
Lord, Amanda
Zantek, Nicole
Harmon, James
机构：
[1] Univ Minnesota, Med Ctr, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Minneapolis, MN USA
[3] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
来源：
CRITICAL CARE MEDICINE | 2018年 / 46卷 / 01期
关键词：
D O I：
10.1097/01.ccm.0000528534.73291.49
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
516
引用
收藏
页码：243 / 243
页数：1
相关论文
共 50 条
  • [41] Four-factor prothrombin complex concentrate (Beriplex® P/N) is superior to three-factor prothrombin complex concentrate for reversal of coumarin anticoagulation
    E Herzog
    F Kaspereit
    W Krege
    P Niebl
    G Dickneite
    Critical Care, 19 (Suppl 1):
  • [42] A European consensus statement on the use of four-factor prothrombin complex concentrate for cardiac and non-cardiac surgical patients
    Erdoes, G.
    Koster, A.
    Ortmann, E.
    Meesters, M., I
    Bolliger, D.
    Baryshnikova, E.
    De Arroyabe, B. Martinez Lopez
    Ahmed, A.
    Lance, M. D.
    Ranucci, M.
    von Heymann, C.
    Agarwal, S.
    Ravn, H. B.
    ANAESTHESIA, 2021, 76 (03) : 381 - 392
  • [43] Evaluation of three-factor prothrombin complex concentrate versus four-factor prothrombin complex concentrate for the urgent reversal of oral anticoagulation.
    Truong, Shawna
    Snyder, Julie
    Celmins, Laura
    PHARMACOTHERAPY, 2017, 37 (06): : E47 - E47
  • [44] Four-factor Prothrombin Complex Concentrate for the Management of Patients Receiving Direct Oral Activated Factor X Inhibitors
    Grottke, Oliver
    Schulman, Sam
    ANESTHESIOLOGY, 2019, 131 (05) : 1153 - 1165
  • [45] The Off-Label Use of Four-Factor Prothrombin Complex Concentrate: A Single Institution Retrospective Study
    Scharman, Carlton D.
    Kim, Edward
    Shatzel, Joseph J.
    Deloughery, Thomas G.
    BLOOD, 2017, 130
  • [46] More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate
    Lindahl, Tomas L.
    Wallstedt, Maria
    Gustafsson, Kerstin M.
    Persson, Egon
    Hillarp, Andreas
    THROMBOSIS RESEARCH, 2015, 135 (03) : 544 - 547
  • [47] FOUR-FACTOR VERSUS THREE-FACTOR PROTHROMBIN COMPLEX CONCENTRATE: IS MORE ALWAYS BETTER?
    Cutshall, B. Tate
    Jones, G. Morgan
    JOURNAL OF EMERGENCY MEDICINE, 2017, 52 (04): : 586 - 587
  • [48] Four-factor prothrombin complex concentrate for the reversal of factor Xa inhibitors for traumatic intracranial hemorrhage
    Dybdahl, Daniel
    Walliser, Grant
    Spalding, M. Chance
    Pershing, Michelle
    Kincaid, Michelle
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2019, 37 (10): : 1907 - 1911
  • [49] FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE IN FACTOR XA INHIBITOR-ASSOCIATED INTRACRANIAL BLEEDING
    Korobey, Matthew
    Sadaka, Farid
    Javed, Muhammad Ali
    Moynihan, Meghin
    Alsaei, Ahmed
    CRITICAL CARE MEDICINE, 2020, 48
  • [50] Four-Factor Prothrombin Complex Concentrate for Urgent Reversal of Vitamin K Antagonists in Patients With Major Bleeding
    Quinlan, Daniel J.
    Eikelboom, John W.
    Weitz, Jeffrey I.
    CIRCULATION, 2013, 128 (11) : 1179 - 1181
12345